Women with a mutation in the breast cancer susceptibility gene 1 (BRCA1) face a high lifetime risk of developing breast and ovarian cancer estimated to be as high as 80 % and 40 %, respectively [1–4]. Here, BRCA1 is linked to ovarian cancer.